Soyfood and isoflavone intake and risk of type 2 diabetes in Vietnamese adults

Background/Objectives: Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	European journal of clinical nutrition Ročník 71; číslo 10; s. 1186 - 1192
Hlavní autoři:	Nguyen, C T, Pham, N M, Do, V V, Binns, C W, Hoang, V M, Dang, D A, Lee, A H
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 01.10.2017 Nature Publishing Group
Témata:	692/499 692/699/2743/137/773 Adult Adults Aged Antidiabetics Asian people Beansprouts Case-Control Studies Clinical Nutrition Confidence intervals Control methods Daidzein Demographics Demography Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - etiology Diabetes Mellitus, Type 2 - prevention & control Disease prevention Epidemiology Feeding Behavior Female Genistein Glycine max Health aspects Health risk assessment Health risks Hospitals Humans Internal Medicine Isoflavones Isoflavones - administration & dosage Isoflavones - blood Male Medicine Medicine & Public Health Metabolic Diseases Middle Aged Nutrition research original-article Plant-based beverages Polyphenols Public Health Regression analysis Risk Risk Factors Soy products Soybean milk Soybean products Soybeans Statistical analysis Surveys and Questionnaires Tofu Type 2 diabetes Vietnam - epidemiology Vietnam
ISSN:	0954-3007, 1476-5640, 1476-5640
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	Background/Objectives: Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults. Subjects/Methods: A hospital-based case-control study was conducted in Vietnam during 2013–2015. A total of 599 newly diagnosed diabetic cases (age 40–65 years) and 599 hospital-based controls, frequency matched by age and sex, were recruited in Hanoi, capital city of Vietnam. Information on frequency and quantity of soyfood and isoflavone intake, together with demographics, habitual diet and lifestyle characteristics, was obtained from direct interviews using a validated and reliable questionnaire. Unconditional logistic regression analyses were performed to examine the association between soy variables and type 2 diabetes risk. Results: Higher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21–0.46; P <0.001). An inverse dose–response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P <0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident. Conclusions: Soyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ISSN:	0954-3007 1476-5640 1476-5640
DOI:	10.1038/ejcn.2017.76